Skip to main content

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Evaluation and characterization of cardiac involvement in patients with Systemic Sclerosis.

Cardiac involvement is one of the most serious internal organ involvements and the leading cause of death in SSc patients. The prevalence is 14% by clinical observation and even higher by autopsy Many SSc patients with cardiac involvement are asymptomatic or underdiagnosed. The condition may progress silently to overt clinical manifestations, including systolic and/or diastolic dysfunction, myocardial ischaemia, myocardial hypertrophy, heart failure, pericardial effusion and arrhythmias. Early detection of cardiac abnormalities is therefore very important. We evaluate cardiac involvement by echocardiography, MR, SPECT, and coronary CT.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Specific Antinuclear antibodies of scleroderma as markers for different clinical patterns.

We want to establish the relationship between the presence of specific autoantibodies for scleroderma (anti-centromere, anti-topoisomerase 1, anti-polymerase III, anti-U3 RNP, Anti-Th/To, Anti-Pm/Scl, anti-Ku) with the different demographic and clinical features as well as with the disease prognosis.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Projects

ESTUDIO DE NUEVOS ANTIGENOS EN ESCLERODERMIA

IP: Carmen Pilar Simeón i Aznar
Collaborators: Vicenç Fonollosa Pla, Alfredo Guillen Del Castillo
Funding agency: Instituto de Salud Carlos III
Funding: 78650
Reference: PI16/02088
Duration: 01/01/2017 - 30/06/2021

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Autoimmunitat i Malaltia Trombòtica (GRC), Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

IP: Carmen Pilar Simeón i Aznar
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: PDJF-2012-01
Duration: 01/01/2013 - 31/12/2013

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Autoimmunitat i malaltia trombòtica, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

The study showing how thrombocytopenia increases the risk of thrombosis in patients with antiphospholipid syndrome has been considered the best paper published in 2021.

Related professionals

Claudia Meza Burgos

Claudia Meza Burgos

Research technician
Stroke research
Read more
Clara Durlach

Clara Durlach

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Eva María Álvarez Enriquez

Eva María Álvarez Enriquez

Administrative
General Services and Infrastructures Unit
Manager
Read more
Eniruqe Alberto Vargas Meouchi

Eniruqe Alberto Vargas Meouchi

Research technician
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.